how does this: The data displays number of reported measles cases children in India in 2005-2021 who received their first and second doses of MMR vaccines (Murugan, 2022). In order to prevent outbreak of measles MCV2 was introduced in India in 2011 to eliminate the disease as increased percentage of effective against measles 93% to 97% (CDC, 2021). The general pattern is that as the coverages of vaccines increases the number of cases decreases before reaching the rate of herd immunity some outlier for example 2014 and 2015 where showing positive correlation even when MCV2 have been introduced. However, from late 2018 which herd immunity is reached shows down trending number of cases. Therefore, the testing result indicate that vaccination coverage has consistently impacted number cases compared with MCV1 coverage. The limitation of this graph is that the age group of children were not specified which means that there is risk of not checking the vaccination for the most vulnerable population. Link with the cliam Government disease management strategies are critical for controlling the spread of disease

Question

how does this: The data displays number of reported measles cases children in India in 2005-2021 who received their first and second doses of MMR vaccines (Murugan, 2022). In order to prevent outbreak of measles MCV2 was introduced in India in 2011 to eliminate the disease as increased percentage of effective against measles 93% to 97% (CDC, 2021). The general pattern is that as the coverages of vaccines increases the number of cases decreases before reaching the rate of herd immunity some outlier for example 2014 and 2015 where showing positive correlation even when MCV2 have been introduced. However, from late 2018 which herd immunity is reached shows down trending number of cases. Therefore, the testing result indicate that vaccination coverage has consistently impacted number cases compared with MCV1 coverage. The limitation of this graph is that the age group of children were not specified which means that there is risk of not checking the vaccination for the most vulnerable population. Link with the cliam Government disease management strategies are critical for controlling the spread of disease

Proving The data is valid with the scope of the claim

Answer 1

The data presented in the statement provides information on reported measles cases among children in India from 2005 to 2021. It also mentions the introduction of the MCV2 vaccine in 2011 and highlights the general pattern of decreasing cases with increased vaccine coverage. The statement further elaborates on specific outlier years and highlights the downward trend in cases since late 2018, indicating the impact of vaccination coverage.

To validate the data's validity, it is stated that the information is sourced from Murugan (2022), suggesting a reliable publication or study. Additionally, the claim is further supported by a reference to the CDC (Centers for Disease Control and Prevention), highlighting that MCV2 is effective against measles at a rate of 93% to 97% (CDC, 2021).

The link between the data and the claim is made by stating that government disease management strategies are critical for controlling the spread of disease. This emphasizes the importance of vaccination coverage and its consistent impact on the number of reported cases.

The limitations of the data are also mentioned, specifically that the age group of children is not specified. This introduces a potential risk of not considering the vaccination status of the most vulnerable population. Nevertheless, the overall statement presents a logical and valid argument by providing supporting evidence and acknowledging potential shortcomings.

Answer 2

To validate the data and support the claim that government disease management strategies are critical for controlling the spread of disease, we can examine the provided information.

1. The data shows the number of reported measles cases in children in India from 2005 to 2021. This indicates that the study covers a significant time period and captures the long-term effects of vaccination strategies.

2. The information mentions the introduction of MCV2 in 2011 to eliminate measles in India. It states that the vaccine was found to be effective against measles in a range of 93% to 97% according to CDC (Centers for Disease Control and Prevention) data from 2021. This provides a specific reference to a reliable source supporting the effectiveness of the vaccine.

3. The general pattern observed in the data is that as vaccination coverage increases, the number of reported measles cases decreases. This correlation suggests that vaccination has a substantial impact on reducing the spread of the disease.

4. The data acknowledges that some outliers, specifically 2014 and 2015, displayed a positive correlation between vaccination coverage and reported cases. However, considering the overall trend and the reduction of cases since herd immunity was reached in late 2018, it supports the claim that vaccination coverage consistently impacts the number of cases.

Additionally, it is mentioned that the age group of children was not specified in the data, which poses a limitation. This highlights the risk that the vaccination status for the most vulnerable age group may not have been fully assessed. However, it does not invalidate the broader trend observed in the data.

Overall, the provided data, along with the information about the introduction and effectiveness of MCV2 and the observed patterns, supports the claim that government disease management strategies, particularly vaccination coverage, are critical for controlling the spread of disease, specifically measles in this case.